0001415889-23-011244.txt : 20230718
0001415889-23-011244.hdr.sgml : 20230718
20230718181458
ACCESSION NUMBER: 0001415889-23-011244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAHAM RICHARD A
CENTRAL INDEX KEY: 0001820036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 231095226
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
form4-07182023_100756.xml
X0508
4
2023-07-14
0001583107
Theravance Biopharma, Inc.
TBPH
0001820036
GRAHAM RICHARD A
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
SVP, RESEARCH & DEVELOPMENT
0
Ordinary Shares
2023-07-14
4
S
0
2322
9.84
D
352068
D
This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.
/s/ Brett A. Grimaud, Attorney-in-Fact
2023-07-18